107 related articles for article (PubMed ID: 4915764)
21. Clinical efficacy of haloperidol in chronic psychotic patients.
Lapolla A
Int J Neuropsychiatry; 1967 Aug; 3():Suppl l:68-77. PubMed ID: 6051725
[No Abstract] [Full Text] [Related]
22. [Use of butyrophenones in the psychiatric treatment of state of excitement in long-term hospitalized patients].
Ronzini F; Bocci U; Luzi T
Riv Sper Freniatr Med Leg Alien Ment; 1970 Oct; 94(5):1163-79. PubMed ID: 5497076
[No Abstract] [Full Text] [Related]
23. [Haloperidol in the treatment of psychotic disorders in old age].
Kobrzyńska E; Chachaj L
Psychiatr Pol; 1982; 16(1-2):13-7. PubMed ID: 7146202
[No Abstract] [Full Text] [Related]
24. The clinical use of piracetam, a new nootropic drug. The treatment of symptoms of senile involution.
Stegink AJ
Arzneimittelforschung; 1972 Jun; 22(6):975-7. PubMed ID: 4559159
[No Abstract] [Full Text] [Related]
25. Agitation and psychosis in dementia.
Ballard C
Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
[No Abstract] [Full Text] [Related]
26. Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol.
Cocito E; Ambrosini G; Arata A; Bevilacqua P; Tortora E
Arzneimittelforschung; 1970 Aug; 20(8):1119-25. PubMed ID: 4921409
[No Abstract] [Full Text] [Related]
27. [A long-acting neuroleptic. 3. Pilot study of penfluridol (R 16341)].
Bobon J; Melon J; Mormont C; Dufrasne M; Pinchard A
Acta Psychiatr Belg; 1970; 70(4):523-51. PubMed ID: 4923798
[No Abstract] [Full Text] [Related]
28. Current attitudes regarding treatment of agitation and psychosis in dementia.
Serby MJ; Roane DM; Lantz MS; Cohen AJ; Turok A; Perlis TE
Am J Geriatr Psychiatry; 2009 Feb; 17(2):174. PubMed ID: 19155750
[No Abstract] [Full Text] [Related]
29. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
30. The differential prediction of response to two anti-psychotic drugs.
Goldstein BJ; Brauzer B; Clyde DJ; Caldwell JM
Psychosomatics; 1969; 10(3):193-7. PubMed ID: 4897844
[No Abstract] [Full Text] [Related]
31. Antipsychotic treatment of psychosis and agitation in the elderly.
Daniel DG
J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
[TBL] [Abstract][Full Text] [Related]
32. Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.
Zaraa AS
Geriatrics; 2003 Oct; 58(10):48-50, 52-3. PubMed ID: 14569642
[No Abstract] [Full Text] [Related]
33. Therapeutic spectrum of sulpiride, haloperidol and lithium: a graphic representation by clinical observation.
Abe K; de Francisco CP
Osaka City Med J; 1976; 22(1):53-6. PubMed ID: 1032418
[No Abstract] [Full Text] [Related]
34. [The role of phychotonic drugs in neuropsychiatry].
Bánki C
Orv Hetil; 1976 Feb; 117(5):283-6. PubMed ID: 1250597
[No Abstract] [Full Text] [Related]
35. [Value of a new activator of cerebral metabolism, Cyprodemanol, in the field of geriatric psychiatry].
Genevieve JM
Encephale; 1970; 59(3):90-5. PubMed ID: 5422001
[No Abstract] [Full Text] [Related]
36. Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.
Petrie WM; Ban TA; Berney S; Fujimori M; Guy W; Ragheb M; Wilson WH; Schaffer JD
J Clin Psychopharmacol; 1982 Apr; 2(2):122-6. PubMed ID: 7042770
[No Abstract] [Full Text] [Related]
37. Haloperidol plasma/red blood cell ratios and clinical efficacy.
Neborsky R; Janowsky DS; Perel J; Munson E; Depry D
Psychopharmacol Bull; 1982 Oct; 18(4):17-20. PubMed ID: 7156285
[No Abstract] [Full Text] [Related]
38. [Results of the use of haloperidol in a service for adults].
Renard P; Larroutis-Bicheron C; Morin Y
Gaz Med Fr; 1965 Apr; 72(8):1746-50. PubMed ID: 5830684
[No Abstract] [Full Text] [Related]
39. Flupenthixol versus haloperidol in acute psychosis.
Parent M; Toussaint C
Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacokinetic of haloperidol decanoate in psychotic patients (author's transl)].
Parent M; Toussaint C; Driesens F; Gelders Y
Acta Psychiatr Belg; 1981; 81(4):399-406. PubMed ID: 7331843
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
